TNF-α induces a decrease in eNOS promoter activity

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 286, Issue 2 30-2, 2004, Pages

  Neumann, Paul ^b   Gertzberg, Nancy ^b   Johnson, Arnold ^a,b,c  

^a Knowledge Management Office   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

^c STRATTON VA MEDICAL CENTER   (United States)

Author keywords

Decoy; Edema; Endothelial nitric oxide synthase; Messenger ribonucleic acid; Permeability; Transcription; Tumor necrosis factor

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GALACTOSIDASE; LUCIFERASE; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR SP3; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BINDING KINETICS; BINDING SITE; CATTLE; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REGULATORY MECHANISM; TRANSCRIPTION INITIATION SITE;

ANIMALS; ANTINEOPLASTIC AGENTS; CATTLE; CELL COUNT; CELL SURVIVAL; CELLS, CULTURED; COLORING AGENTS; DNA-BINDING PROTEINS; ENDOTHELIUM, VASCULAR; GATA4 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC COMPLEMENTATION TEST; HUMANS; LUNG; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); SP3 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TRYPAN BLUE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1642459419     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Alonso J, Sanchez de Miguel L, Monton M, Casado S, and Lopez-Farre A. Endothelial cytosolic proteins bind to the 3′ untranslated region of endothelial nitric oxide synthase mRNA: regulation by tumor necrosis factor-α. Mol Cell Biol 17: 5719-5726, 1997.
2. Bouloumie A, Schini-Kerth VB, and Busse R. Vascular endothelial growth factor upregulates nitric oxide synthase expression in endothelial cells. Cardiovasc Res 41: 773-780, 1999.
3. Bove K, Neumann P, Gertzberg N, and Johnson A. eNOS mediates TNF-induced endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 280: L914-L922, 2001.
4. Beutler B, Milsark IW, and Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from the lethal effect of endotoxin. Science 229: 869-871, 1985.
5. Cieslik K, Zembowicz A, Tang JL, and Wu KK. Transcriptional regulation of endothelial nitric-oxide synthase by lysophosphatidycholine. J Biol Chem 273: 14885-14890, 1998.
6. Del Vecchio PJ, Siflinger-Birnboim A, Belloni PN, Holleran LA, Lum H, and Malik AB. Culture and characterization of pulmonary microvascular endothelial cells. In Vitro Cell Dev Biol 28A: 711-715, 1992.
7. Ferro T, Clements R, Neumann P, Gertzberg N, and Johnson A. Protein kinase Cα mediates endothelial barrier dysfunction induced by TNF-α. Am J Physiol Lung Cell Mol Physiol 278: L1107-L1117, 2000.
8. Ferro TJ, Gertzberg N, Selden L, Neumann P, and Johnson A. Endothelial barrier dysfunction and p42 oxidation induced by TNF-α are mediated by nitric oxide. Am J Physiol Lung Cell Mol Physiol 272: L979-L988, 1997.
9. Forstermann U, Boissel JP, and Kleinert H. Expressional control of the constitutive isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J 12: 773-790, 1998.
10. Gertzberg N, Clements R, Jaspers I, Ferro TJ, Neumann P, Flescher E, and Johnson A. Tumor necrosis factor-α induced activating protein-1 activity is modulated by nitric oxide-mediated protein kinase G activation. Am J Respir Cell Mol Biol 22: 105-115, 2000.
11. Gumina RJ, Kirschbaum NE, Piotrowski K, and Newman PJ. Characterization of the human platelet/endothelial cell adhesion molecule-1 promoter: identification of a GATA-2 binding element required for optimal transcriptional activity. Blood 89: 1260-1269, 1997.
12. Harrison DG, Inoue N, Ohara Y, and Fukai T. Modulation of endothelial cell nitric oxide synthase expression. Jpn Circ J 60: 815-821, 1996.
13. Hocking DC, Phillips PG, Ferro PJ, and Johnson A. Mechanisms of pulmonary edema induced by tumor necrosis factor-α. Circ Res 67: 68-77, 1990.
14. Johnson J, Meyrick B, Jesmok G, and Brigham KL. Human recombinant tumor necrosis factor-α infusion mimics endotoxemia in sheep. J Appl Physiol 66: 1448-1454, 1989.
15. Karantzoulis-Fegaras F, Antoniou H, Lai SL, Kulkarni G, D'Abreo C, Wong GK, Miller TL, Chan Y, Atkins J, Wang Y, and Marsden PA. Characterization of the human endothelial nitric-oxide synthase promoter. J Biol Chem 274: 3076-3093, 1999.
16. Klenert H, Wallerath T, Euchenhofer C, Ihrig-Biedert I, Li H, and Forstermann U. Estrogens increase transcription of the human endothelial NO synthase gene: analysis of the transcription factors involved. Hypertension 31: 582-588, 1998.
17. Laney JD and Biggin MD. Redundant control of Ultrabithorax by zeste involves functional levels of zeste protein binding at the Ultrabithorax promoter. Development 122: 2303-2311, 1996.
18. Laufs U and Liao JK. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 273: 24266-24271, 1998.
19. Laumonnier Y, Nadaud S, Agrapart M, and Soubrier F. Characterization of an upstream enhancer region in the promoter of the human endothelial nitric-oxide synthase gene. J Biol Chem 275: 40732-40741, 2000.
20. Li H, Oehrlein SA, Wallerath T, Ihrig-Biedert I, Wohlfart P, Ulshofer T, Jessen T, Herget T, Forstermann U, and Kleinert H. Activation of protein kinase C alpha and/or epsilon enhances transcription of the human endothelial nitric oxide synthase gene. Mol Pharmacol 53: 630-637, 1998.
21. Lowry JA and Atchley WR. Molecular evolution of the GATA family of transcription factors: conservation within the DNA-binding domain. J Mol Evol 50: 103-115, 2000.
22. Marumo T, Nakaki T, Adachi H, Esumi H, Suzuki H, Sauta T, and Kato R. Nitric oxide synthase mRNA in endothelial cell: synergistic induction by interferon-γ, tumor necrosis factor-α and lipopolysaccharide and inhibition by dexamethasone. Jpn J Pharmacol 63: 327-334, 1993.
23. Matsumoto N, Laub F, Aldabe R, Zhang W, Ramirez F, Yoshida T, and Terada M. Cloning the cDNA for a new human zinc finger protein defines a group of closely related Kruppel-like transcription factors. J Biol Chem 273: 28229-28237, 1998.
24. Minami T, Rosenberg RD, and Aird WC. Transforming growth factor-β1-mediated inhibition of the flk1/KDR gene is mediated by a 5′-untranslated region palindromic GATA site. J Biol Chem 276: 5395-5402, 2001.
25. Moncada S, Palmer MJ, and Higgs A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43: 109-141, 1991.
26. 1-adrenergic agonist-responsive transcription of the endothelin-1 gene in cardiac myocytes. J Biol Chem 275: 13721-13726, 2000.
27. Navarro-Antolin J, Rey-Campos O, and Lamas S. Transcriptional induction of endothelial nitric oxide gene by cyclosporine A. A role for activator protein-1. J Biol Chem 275: 3075-3080, 2000.
28. Phillpsen S and Guntram G. A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. Nucleic Acids Res 27: 2991-3000, 1999.
29. Sanchez de Miguel L, Alonso J, Gonzalez-Fernandez F, de la Osada J, Monton M, Feo Rodriguez JA, Guerra JI, Arriero MM, Rico L, Casado S, and Lopez-Farre A. Evidence that an endothelial cytosolic protein binds to the 3′-untranslated region of endothelial nitric oxide synthase mRNA. J Vasc Res 26: 201-208, 1999.
30. Steel RGD and Torrie JH. Principles and Procedures of Statistics: a Biometrical Approach (2nd ed). New York: McGraw-Hill, 1980.
31. Suzuki YJ, Shi SS, and Blumberg JB. Modulation of angiotensin II signaling for GATA4 activation by homocysteine. Antioxid Redox Signal 1: 233-238, 1999.
32. Tabata M, Tarumoto T, Ohmine K, Furukawa Y, Hatake K, Ozawa K, Hasegawa Y, Mukai H, Yamamoto M, and Imagawa S. Stimulation of GATA-2 as a mechanism of hydrogen peroxide suppression in hypoxia-induced erythropoietin gene expression. J Cell Physiol 186: 260-267, 2001.
33. Tang JL, Zembowicz A, Xu XM, and Wu KK. Role of Sp1 in transcriptional activation of human nitric oxide synthase type III gene. Biochem Biophys Res Commun 213: 673-680, 1995.
34. Tracey KJ, Lorry SF, and Cerami A. Cachectin/TNF in septic shock and septic adult respiratory distress syndrome. Am Rev Respir Dis 138: 1377-1379, 1988.
35. Venema RC, Nishida K, Alexander RW, Harrison DG, and Murphy TJ. Organization of the bovine gene encoding the endothelial nitric oxide synthase. Biochim Biophys Acta 1218: 413-420, 1994.
36. Vlach J, Garcia A, Jacque JM, Rodriques MS, Michelson S, and Virelizier JL. Induction of Sp1 phosphorylation and NF-κB-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid. Virology 208: 753-761, 1995.
37. Wariishi S, Miyahara K, Toda K, Ogoshi S, Doi Y, Ohnishi S, Mitsui Y, Yui Y, Kawai C, and Shizuta Y. A SP1 binding site in the GC-rich region is essential for a core promoter activity of the human endothelial nitric oxide synthase gene. Biochem Biophys Res Commun 16: 729-735, 1995.
38. Yoshizumi M, Perrella MA, Burnett JC Jr, and Lee ME. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 73: 205-209, 1993.
39. Zhang J, Patel JM, Li YD, and Block ER. Proinflammatory cytokines downregulate gene expression and activity of constitutive nitric oxide synthase in porcine pulmonary artery endothelial cells. Res Commun Mol Pathol Pharmacol 96: 71-87, 1996.
40. Zhang R, Min W, and Sessa WC. Functional analysis of the human endothelial nitric oxide synthase promoter. Sp1 and GATA factors are necessary for basal transcription in endothelial cells. J Biol Chem 270: 15320-15326, 1995.
41. Ziegler T, Silacci P, Harrison VJ, and Hayoz D. Nitric oxide synthase expression in endothelial cells exposed to mechanical forces. Hypertension 32: 351-355, 1998.